There are 2 versions of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (5)

Short Titles

Short Titles - Senate

Short Titles as Reported to Senate

CREATES Act of 2018
Creating and Restoring Equal Access to Equivalent Samples Act of 2018

Short Titles as Introduced

CREATES Act of 2017
Creating and Restoring Equal Access To Equivalent Samples Act of 2017

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.


Actions Overview (2)

Date
06/21/2018Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
04/27/2017Introduced in Senate

All Actions (4)

Date
06/21/2018Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
Action By: Senate
06/21/2018Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
06/14/2018Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
04/27/2017Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S2619)
Action By: Senate

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Judiciary04/27/2017 Referred to
06/14/2018 Markup by
06/21/2018 Reported by

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.


Subjects (6)


Latest Summary (1)

There is one summary for S.974. View summaries

Shown Here:
Introduced in Senate (04/27/2017)

Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017

This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.